Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huimei Yi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Mutation Research|October 10, 2025
Deciphering the molecular mechanism of YY1/HIF1A modulating ovarian cancer angiogenesis based on single-cell transcriptomics technologyXiyun Quan, Huimei Yi, Meiyuan Huang, et al.
Discover Oncology|October 21, 2025
Identification and characterization of lLF2 as a prognostic biomarker in HER2-positive breast cancer using Mendelian randomization and machine learningXiyun Quan, Yi Deng, Meiyuan Huang, et al.
Peerj|April 18, 2025
LASSO-derived nomogram prediction model for lymph node metastasis in colorectal cancer: a retrospective analysisXiyun Quan, Yi Deng, Zhimin Liu, et al.
Frontiers in Oncology|June 7, 2021
Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future PerspectivesHuimei Yi, Ying Li, Yuan Tan, et al.
Anti-Cancer Drugs|November 4, 2017
Autophagy and doxorubicin resistance in cancerChao Chen, Lu Lu, Shichao Yan, et al.
Journal of Cancer|April 25, 2020
Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem CellsHuimei Yi, Mi Wu, Qiuting Zhang, et al.
Journal of Cancer|November 9, 2018
Nucleolar stress: is there a reverse version?Lu Lu, Huimei Yi, Chao Chen, et al.
Nanoscale Research Letters|September 15, 2019
Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer CellsDi Wu, Yao Chen, Shun Wen, et al.
Journal of Cancer|June 7, 2021
Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/FerroptosisQiuting Zhang, Huimei Yi, Hui Yao, et al.
Biomaterials Science|January 13, 2021
CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cellsShichao Yan, Da Tang, Zhangyong Hong, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mutation Research|October 10, 2025
Deciphering the molecular mechanism of YY1/HIF1A modulating ovarian cancer angiogenesis based on single-cell transcriptomics technologyXiyun Quan, Huimei Yi, Meiyuan Huang, et al.
Discover Oncology|October 21, 2025
Identification and characterization of lLF2 as a prognostic biomarker in HER2-positive breast cancer using Mendelian randomization and machine learningXiyun Quan, Yi Deng, Meiyuan Huang, et al.
Peerj|April 18, 2025
LASSO-derived nomogram prediction model for lymph node metastasis in colorectal cancer: a retrospective analysisXiyun Quan, Yi Deng, Zhimin Liu, et al.
Frontiers in Oncology|June 7, 2021
Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future PerspectivesHuimei Yi, Ying Li, Yuan Tan, et al.
Anti-Cancer Drugs|November 4, 2017
Autophagy and doxorubicin resistance in cancerChao Chen, Lu Lu, Shichao Yan, et al.
Journal of Cancer|April 25, 2020
Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem CellsHuimei Yi, Mi Wu, Qiuting Zhang, et al.
Journal of Cancer|November 9, 2018
Nucleolar stress: is there a reverse version?Lu Lu, Huimei Yi, Chao Chen, et al.
Nanoscale Research Letters|September 15, 2019
Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer CellsDi Wu, Yao Chen, Shun Wen, et al.
Journal of Cancer|June 7, 2021
Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/FerroptosisQiuting Zhang, Huimei Yi, Hui Yao, et al.
Biomaterials Science|January 13, 2021
CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cellsShichao Yan, Da Tang, Zhangyong Hong, et al.
Pageof 2